Novel p38 mitogen-activated protein kinase inhibitor R-130823 protects cartilage by down-regulating matrix metalloproteinase-1,-13 and prostaglandin E2 production in human chondrocytes

scientific article published on 24 August 2005

Novel p38 mitogen-activated protein kinase inhibitor R-130823 protects cartilage by down-regulating matrix metalloproteinase-1,-13 and prostaglandin E2 production in human chondrocytes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.INTIMP.2005.07.009
P698PubMed publication ID16399619

P2093author name stringKotaro Sugimoto
Yoshihiro Wada
Kohei Shimada
Shigeru Ushiyama
Tomio Kimura
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectprostaglandin E2Q416554
P304page(s)144-155
P577publication date2005-08-24
P1433published inInternational ImmunopharmacologyQ15751306
P1476titleNovel p38 mitogen-activated protein kinase inhibitor R-130823 protects cartilage by down-regulating matrix metalloproteinase-1,-13 and prostaglandin E2 production in human chondrocytes
P478volume6

Reverse relations

cites work (P2860)
Q51055833Biochemical and Biological Attributes of Matrix Metalloproteinases.
Q37310621Immunomodulatory and anti-inflammatory effects of chondroitin sulphate
Q38836225Intricate Functions of Matrix Metalloproteinases in Physiological and Pathological Conditions.
Q39563568Matrix metalloproteinase-13 expression in IL-1β-treated chondrocytes by activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT pathways
Q42136540Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Q42150940Reduced limb length and worsened osteoarthritis in adult mice after genetic inhibition of p38 MAP kinase activity in cartilage

Search more.